SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-002837
Filing Date
2023-01-30
Accepted
2023-01-30 06:02:00
Documents
12
Period of Report
2023-01-26
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34505
  Complete submission text file 0001493152-23-002837.txt   205493

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adxs-20230126.xsd EX-101.SCH 3236
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adxs-20230126_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adxs-20230126_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3416
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-36138 | Film No.: 23565084
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences